StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.67−0.19 (-1.93%)

Close on Nov 16, 2026Market cap $363.80MP/E –Yield –

Contineum Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Contineum Therapeutics

Contineum Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Contineum Therapeutics figures

See a number that looks wrong?